The phosphatidylinositol 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) signaling, as a key oncogenic pathway in various cancers, is clearly emerging as another important mechanism to promote CRPC [9]. This evidence concerns the gene MTOR and cancer.